Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracyclines”

352 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 352 results

Large-scale testing (Phase 3)Study completedNCT00931138
What this trial is testing

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 420
Testing effectiveness (Phase 2)WithdrawnNCT03872505
What this trial is testing

Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Cedars-Sinai Medical Center
Testing effectiveness (Phase 2)UnknownNCT03412955
What this trial is testing

A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes

Who this might be right for
Breast Cancer
Tan Tock Seng Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00369655
What this trial is testing

VEGF Trap in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT01966471
What this trial is testing

Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 1,846
Testing effectiveness (Phase 2)Study completedNCT00212069
What this trial is testing

Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer

Who this might be right for
Metastatic Breast Cancer
National University Hospital, Singapore 30
Not applicableStudy completedNCT05923242
What this trial is testing

Translating ECHOS2 Into an mHealth Platform

Who this might be right for
Childhood CancerCardiac ToxicityPediatric Cancer
Washington University School of Medicine 73
Testing effectiveness (Phase 2)Study completedNCT01019577
What this trial is testing

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Who this might be right for
Metastatic Breast Cancer
R-Pharm 54
Large-scale testing (Phase 3)UnknownNCT01501669
What this trial is testing

Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
National Cancer Center, Korea 222
Testing effectiveness (Phase 2)Study completedNCT01446016
What this trial is testing

Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)

Who this might be right for
Breast NeoplasmsBreast Cancer
The Methodist Hospital Research Institute 38
Large-scale testing (Phase 3)Ended earlyNCT00060671
What this trial is testing

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, FollicularLymphoma, Mixed-Cell, FollicularLymphoma, Small Cleaved-Cell, Follicular+1 more
CTI BioPharma 800
Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Not applicableLooking for participantsNCT05467111
What this trial is testing

Cardioprotective Effect of Acute Exercise in Breast Cancer Patients

Who this might be right for
Early-stage Breast Cancer
Technical University of Madrid 40
Not applicableStudy completedNCT01415999
What this trial is testing

Cardiovascular Function in Adult Survivors of Childhood Malignancies

Who this might be right for
Childhood Cancers
The University of Hong Kong 142
Not applicableStudy completedNCT03964142
What this trial is testing

Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity

Who this might be right for
CardiotoxicityCardiac Rehabilitation
Hospital Clinico Universitario de Santiago 122
Testing effectiveness (Phase 2)Study completedNCT00334802
What this trial is testing

Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 62
Testing effectiveness (Phase 2)UnknownNCT04848454
What this trial is testing

Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy

Who this might be right for
HER2-negative Breast CancerNeoadjuvant TherapyPathological Complete Response+3 more
Peking University First Hospital 30
Not applicableStudy completedNCT01071473
What this trial is testing

Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy

Who this might be right for
Cardiomyopathy
St. Jude Children's Research Hospital 22
Not applicableStudy completedNCT03553654
What this trial is testing

Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity

Who this might be right for
Neoplasms
University of California, San Diego 19
Testing effectiveness (Phase 2)UnknownNCT02829008
What this trial is testing

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Chinese Academy of Medical Sciences 120
Load More Results